Kymera Therapeutics, Inc. (KYMR)
72.75
+2.01
(+2.84%)
USD |
NASDAQ |
Jan 22, 16:00
72.75
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Market Cap: 5.234B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 79.38B |
| Gilead Sciences, Inc. | 162.72B |
| Cytokinetics, Inc. | 7.933B |
| TG Therapeutics, Inc. | 5.025B |
| Protagonist Therapeutics, Inc. | 5.298B |
Market Cap Related Metrics
| PS Ratio | 136.36 |
| PEG Ratio | -0.3714 |
| Price to Book Value | 5.532 |
| Price | 72.75 |
| Earnings Yield | -4.94% |
| PEGY Ratio | -0.3714 |